PAX6通过MEK/ERK信号通路抑制肝星状细胞活化和增殖实验研究

doi:10.3969/j.issn.1672-5069.2022.03.004

摘要/Abstract

摘要： 目的探讨PAX6通过丝裂原活化蛋白激酶(MEK)/细胞外调节蛋白激酶(ERK)信号通路抑制肝星状细胞活化和增殖的效果。方法取LX2肝星状细胞,分为对照组、PAX6 inhibitor组和PAX6 mimics组。采用CCK-8试剂盒测定细胞增殖,采用油红O染色测定细胞分化水平,使用流式细胞仪分析细胞凋亡,采用RT-PCR法和蛋白印迹法测定细胞PAX6、MEK和ERK mRNA和蛋白表达水平。结果 PAX6 inhibitor组细胞PAX6 mRNA水平、凋亡率和G1期分别为(1.49±0.23)、(2.70±0.85)%和(59.02±1.25)%,显著低于LX2肝星状细胞组【分别为(1.85±0.19)、(3.40±0.47)%和(64.66±1.41)%,P<0.05】,而细胞增殖、存活率、分化率、MEK和ERK mRNA和蛋白水平分别为(0.79±0.03)、(73.35±9.74)%、(49.37±4.24)%、(2.55±0.43)、(3.90±0.49)、(0.89±0.15)和(1.17±0.17),显著高于LX2肝星状细胞组【分别为(0.58±0.05)、(60.74±9.24)%、(29.35±4.47)%、(2.67±0.47)、(4.55±0.50)、(0.74±0.14)和(1.35±0.16),P<0.05】;PAX6 mimics组细胞PAX6 mRNA水平、凋亡率和G1期分别为(2.67±0.20)、(6.70±1.04)%和(66.38±1.35)%,显著高于LX2肝星状细胞组【分别为(1.85±0.19)、(3.40±0.47)%和(64.66±1.41)%, P<0.05】,而细胞增殖、存活率、分化率、MEK和ERK mRNA和蛋白水平分别为(0.40±0.04)、(52.24±5.57)% 、(13.85±3.35)%、(1.94±0.53)、(1.45±0.42)、(0.53±0.15)和(0.53±0.16),显著低于LX2肝星状细胞组【分别为(0.58±0.05)、(60.74±9.24)%、(29.35±4.47)%、(2.67±0.47)、(4.55±0.50)、(0.74±0.14)和(1.35±0.16),P<0.05】。结论 PAX6过表达可抑制肝星状细胞活化和增殖,促进其凋亡,其机制可能与PAX6过表达可抑制肝星状细胞MEK和ERK表达进而抑制了MEK/ERK通路的激活有关。

关键词: 肝星状细胞, PAX6, MEK/ERK信号通路, 细胞活化, 细胞增殖, 体外

Abstract: Objective The purpose of this experiment was to investigate the effect of PAX6 on inhibition of activation and proliferation of hepatic stellate cells (HSCs) by through MEK/ERK signaling pathway. Methods The LX2 HSCs were divided into control, PAX6 inhibitor and PAX6 mimics group and managed accordingly. The cell proliferation was determined by CCK-8 kit, the cell differentiation was detected by oil red O staining, the cell apoptosis was analyzed by flow cytometry, and PAX6, MEK and ERK mRNA and their protein expression were assayed by RT-PCR and Western blotting, respectively. Results The PAX6 mRNA level, apoptosis rate and G1 stage in PAX6 inhibitor-intervened group were (1.49±0.23), (2.70±0.85)% and (59.02±1.25)%, significantly lower than [(1.85± 0.19), (3.40±0.47)% and (64.66±1.41)%, respectively, P<0.05] in LX2 HSCs, and the cell proliferation, survival rate, differentiation rate, MEK and ERK mRNA and their protein expression in PAX6 inhibitor-intervened group were (0.79±0.03), (73.35±9.74)%, (49.37±4.24)%, (2.55±0.43), (3.90±0.49), (0.89±0.15) and (1.17±0.17), significantly higher than [(0.58±0.05), (60.74±9.24)%, (29.35±4.47)%, (2.67±0.47), (4.55±0.50), (0.74±0.14) and (1.35±0.16), respectively, P<0.05] in the control; the PAX6 mRNA level, apoptosis rate and G1 stages in PAX6 mimics-intervened group were (2.67±0.20), (6.70±1.04)% and (66.38±1.35)%, significantly higher than [(1.85± 0.19), (3.40±0.47)% and (64.66±1.41)%, respectively, P<0.05] in the control, and the cell proliferation, survival rate, differentiation rate, MEK and ERK mRNA and their protein expression in PAX6 mimics group were (0.40±0.04), (52.24±5.57)%, (13.85±3.35)%, (1.94±0.53), (1.45±0.42), (0.53±0.15) and (0.53±0.16), significantly lower than [(0.58 ±0.05), (60.74±9.24)%, (29.35±4.47)%, (2.67±0.47), (4.55±0.50), (0.74±0.14) and (1.35±0.16), respectively, P<0.05] in the control. Conclusion The PAX6 overexpression could inhibit the activation and proliferation of hepatic stellate cells, and promote cell apoptosis. The mechanism involved might be related to the inhibition of MEK and ERK expression and MEK/ERK pathway in hepatic stellate cells.

Key words: Hepatic stellate cells, PAX6, MEK/ERK signaling pathway, Cell activation, Cell proliferation, In vitro

白亮, 王宝太, 高志峰, 蒋安, 梁金强. PAX6通过MEK/ERK信号通路抑制肝星状细胞活化和增殖实验研究[J]. 实用肝脏病杂志, 2022, 25(3): 318-322.

Bai Liang, Wang Baotai, Gao Zhifeng, et al. PAX6 inhibiting activation and proliferation of hepatic stellate cells through MEK/ERK signaling pathway in vitro[J]. Journal of Practical Hepatology, 2022, 25(3): 318-322.

参考文献

[1] Barry AE, Baldeosingh R, Lamm R, et al. Hepatic stellate cells and hepatocarcinogenesis. Front Cell Dev Biol, 2020, 8: 709.
[2] An P, Wei LL, Zhao S, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun, 2020, 11(1): 2362.
[3] 吉家兴,马俊,李博,等.黄芩素通过Smad信号通路抑制TGF-β1诱导的HSC-T6细胞活化.中南医学科学杂志,2020,48(3):250-252.
[4] Pedersen HR, Baraas RC, Landsend ECS, et al. PAX6 genotypic and retinal phenotypic characterization in congenital aniridia. Invest Ophthalmol Vis Sci, 2020, 61(5): 14.
[5] Williamson KA, Hall HN, Owen LJ, et al. Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA–protein interaction. Genet Med, 2020, 22(3): 598-609.
[6] Xu Y, Xi J, Wang G, et al. PAUPAR and PAX6 sequentially regulate human embryonic stem cell cortical differentiation. NucleicAcids Res, 2021, 49(4): 1935-1950.
[7] Degirmenci U, Wang M, Hu J. Targetingaberrant RAS/RAF/MEK/ERK signaling for cancer therapy. Cells, 2020, 9(1):198.
[8] Akula SM, Abrams SL, Steelman LS,et al. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opin Ther Targets, 2019, 23(11):915-929.
[9] Yang S, Liu G. Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncol Lett, 2017, 13(3):1041-1047.
[10] Jeng KS, Lu SJ, Wang CH,et al. Liver fibrosis and inflammation under the control of ERK2. Int J Mol Sci, 2020, 21(11):3796.
[11] Sheng J, Wang L, Tang PMK, et al. Smad3 deficiency promotes beta cell proliferation and function in db/db mice via restoring Pax6 expression. Theranostics, 2021, 11(6): 2845-2859.
[12] Yu F, Zhang W, Yan C, et al. PAX6, modified by SUMOylation, plays a protective role in corneal endothelial injury. Cell Death Dis, 2020, 11(8):683.
[13] Aryal S, Viet J, Weatherbee BAT, et al. The cataract-linked RNA-binding protein Celf1 post-transcriptionally controls the spatiotemporal expression of the key homeodomain transcription factors Pax6 and Prox1 in lens development. Hum Genet, 2020, 139(12): 1541-1554.
[14] Jiang Q, Xing W, Cheng J, et al. Knockdown of lncRNA XIST suppresses cell tumorigenicity in human non-small cell lung cancer by regulating mir-142-5p/PAX6 axis. OncoTargets Ther, 2020, 13: 4919-4929.
[15] Xiao B, Liu F, Jin YH, et al. Renal sympathetic denervation attenuates left ventricle hypertrophy in spontaneously hypertensive rats by suppressing the Raf/MEK/ERK signaling pathway. Clin Exp Hypertens, 2021, 43(2): 142-150.
[16] May V, Johnson GC, Hammack SE, et al. PAC1 receptor internalization and endosomal MEK/ERK activation is essential for PACAP-mediated neuronal excitability. J Mol Neurosci, 2021, 71(8):1536-1542.
[17] Lin S, Li Q, Jiang S, et al. Crocetin ameliorates chronic restraint stress-induced depression-like behaviors in mice by regulating MEK/ERK pathways and gut microbiota. J Ethnopharmacol, 2021, 268: 113608.
[18] Zhang H, Corredor ALG, Messina-Pacheco J, et al. REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway. CommunBiol, 2021, 4(1): 688.
[19] Chen PC, Hsueh YW, Lee YH, et al. FGF primes angioblast formation by inducing ETV2 and LMO2 via FGFR1/BRAF/MEK/ERK. Cell Mol Life Sci, 2021, 78(5): 2199-2212.
[20] Kumar D, Patel SA, Hassan MK, et al. Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status. Cell Death Dis, 2021, 12(4): 389.